UWM
CMMB

Urban Wealth Management’s Chemomab Therapeutics CMMB Stock Holding History

Urban Wealth Management’s Portfolio CMMB Stock Details CMMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$10K Buy
+691
New +$9.63K 0.03% 199

Other funds holding CMMB

CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Urban Wealth Management's CMMB Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Chemomab Therapeutics (CMMB) in Q2 2022: 691 shares worth $10K. The stake represents 0.03% of the portfolio and ranks #199 among its holdings.

15 funds tracked by Wall St. Rank hold CMMB as of Q2 2022.

  • Urban Wealth Management held 691 shares of Chemomab Therapeutics worth $10K as of Q2 2022.
  • Chemomab Therapeutics was a new Urban Wealth Management position in Q2 2022.
  • Chemomab Therapeutics made up 0.03% of Urban Wealth Management's portfolio in Q2 2022, its #199 holding.
  • 15 funds tracked by Wall St. Rank held Chemomab Therapeutics as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.